Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
TORONTO, June 21 2016 /CNW/ - Mr. Eugene Melnyk announced today that he sold 1,463,365 common shares of Acerus Pharmaceuticals Corporation (TSX: ASP) ("Acerus"), on June 9, 2016, through the...
Defendants include Chairman Ian Ihnatowycz and President Tom Rossi TORONTO, April 5, 2016 /CNW/ - Eugene Melnyk, a significant shareholder in Acerus Pharmaceuticals Corporation (TSX:ASP), today...
Damage claims of $145 million for gross mismanagement TORONTO, March 9, 2016 /CNW/ - Eugene Melnyk announced today that a legal proceeding has been commenced against Acerus Pharmaceuticals...
TORONTO, July 25, 2014 /CNW/ - Mr. Eugene Melnyk announced today that he has sold 200,000 common shares of Trimel Pharmaceuticals Corporation (TSX: TRL) ("Trimel") through the facilities of the...
TORONTO, Nov. 3 /CNW/ - Eugene Melnyk, founder and former Chairman of the Board of Biovail Corporation (NYSE/TSX: BVF) renamed Valeant Pharmaceuticals International Inc. (NYSE/TSX: VRX), today...
Eugene Melnyk comments on decision issued yesterday in the Biovail Corporation (NYSE/TSX: BVF) case by the Ontario Securities Commission: TORONTO, Oct. 1 /CNW/ - "The Commission's decision relates...
TORONTO, Sept. 27 /CNW/ - Eugene Melnyk sent the following letter to the Boards and Management of Biovail Corporation and Valeant Pharmaceuticals International and to the United States Securities and ...
TORONTO, March 22 /CNW/ - Eugene Melnyk, founder of Biovail Corporation (NYSE,TSX:BVF), has sold substantially all of his Biovail Corporation holdings. Since November 24, 2009, Mr. Melnyk has sold...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.